Buscar dentro
200-066-2
Palabra clave:'200-066-2'
Mostrando 1-1 of 1 resultado para "200-066-2" en el plazo de Papeles
AIDS research and human retroviruses, 32(1), 32-43 (2015-09-29)
Oral preexposure prophylaxis (PrEP) trials report disparate efficacy attributed to variable adherence. HPTN 066 was conducted to establish objective, quantitative benchmarks for discrete, regular levels of adherence using directly observed dosing of tenofovir (TFV) disoproxil fumarate (TDF)/emtricitabine (FTC). Healthy, HIV-uninfected
Página 1 de 1